Shares in NMC Health and Finablr plunged on Wednesday after two major shareholders launched a discounted share sale in the London-listed groups, weeks after NMC was hit by a short-selling attack by US firm Muddy Waters.
The healthcare firm’s vice-chairman Khaleefa Al Muhairi and its second-largest shareholder Saeed Al Qebaisi have together sold NMC shares worth 375 million pounds ($493 million).
The deal was priced at 1,200 pence per share, a bookrunner said, adding that the sale was oversubscribed. The price is at a discount of about 20 percent to NMC’s last close.
Qebaisi and Muhairi have also sold about 6 percent of total shares in Finablr for roughly $72 million. The payments firm is co-chaired by Bavaguthu Raghuram Shetty, also the founder and co-chairman of NMC.
Shares in Finablr, whose ransomware-hit Travelex unit is also chaired by Muhairi, were sold at a discounted 135 pence per share.
NMC shares were down 15.3 percent at 1,266.5 pence at 1528 GMT, while those of Finablr were 17.2 percent lower at 127.9 pence. Earlier, Finablr stock hit a record low of 123.2 pence.
NMC, United Arab Emirates’ largest private healthcare provider, launched an independent review of its finances after short-seller Muddy Waters questioned the value of its assets and cash balance while announcing a short position.
Short selling involves borrowing an asset and selling it with the aim of buying it back at a cheaper price for profit.
At Wednesday’s session low, NMC had lost nearly 3 billion pounds in market value since the report was launched on December 17. It has denied the allegations.
The two investors sold the shares to repay some of their debt and the debt of some corporate entities owned by them, the bookrunner said.
“Given the dramatic share price moves in the second half of December, this was the obvious first window for launching the sale,” a source familiar with the transaction told Reuters.
The sale price factored in all the context around Muddy Waters, the independent investigation and the size of the sale, the source said. “This is the discount the market is willing to buy at.”
NMC on its part said the sale was not related to its performance or prospects, adding the shareholders “remain supportive”.
Finablr declined to comment. Credit Suisse and Deutsche Bank managed the sales.
Muhairi will retain a 12.5 percent stake in NMC, while Qebaisi will keep a 4.7 percent holding. The investors jointly hold roughly an additional 7 percent in NMC through Infinite Investment.
Reuters reported last year that two groups were bidding for a 40 percent stake in NMC, jointly owned by Qebaisi, Muhairi, and Infinite Investment.
The investors could not be reached for comment.
NMC Health launches independent review after short seller attackNMC Health has launched an independent review of its books, seeking to reassure investors after US short-selling firm Muddy Waters last week ... Business
NMC Health’s shares plunge 28 pct on the London Stock ExchangeLondon-listed NMC Health PLC saw its shares plunge 28 percent on Tuesday after equity research firm Muddy Waters raised serious doubts about the Abu ... Business
NMC Health, Hassana Investment sign agreement to build Saudi healthcare networkNMC Health said it has signed an agreement with Hassana Investment Company, the investment arm of the General Organization for Social Insurance (GoSI) ... Economy
NMC Health looks to acquisition-led growth, targets Saudi ArabiaNMC Health, the UAE-based healthcare provider, plans to expand in Europe and the Gulf, especially Saudi Arabia, to retain its recently won place ... Economy